content

NHS Should Not Employ 5 COVID Therapies, According To NICE

Five COVID-19 therapies, including Merck & Co.'s antiviral tablet for high-risk patients, have been recommended for discontinuation by Britain's agency that decides whether medications...

IGBA- 2022 WHO Biosimilar Roadmap Facilitates Accessibility

According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline from the International Generic and Biosimilar Medicines Association...

Abu Dhabi Airports Joins Pharma.Aero As Strategic Member

As a strategic member representing the Middle East, Abu Dhabi Airports has joined Pharma.Aero, a global member network for life science and medical technology...

GHIT Fund Invests ยฅ790M On Neglected Tropical Disease Items

Two neglected tropical illnesses, lymphatic filariasis and onchocerciasis, will receive a combined investment of about 790-million-yen ($5.3 million) from the Global Health Innovative Technology...

Malvern Panalytical and Applied Photophysics announce distribution agreement for Protein Stable’s SUPR-DSF

Malvern Panalytical (Malvern, UK) and Applied Photophysics (Leatherhead, UK) have announced their commercial agreement for Malvern Panalytical to distribute Protein Stableโ€™s microplate-based differential scanning...

Tjoapack strengthens its Injectables offering with addition of pre-filled syringes assembly and packaging service

Global pharmaceutical contract packaging organisation (CPO), Tjoapack has invested in a new high-speed packaging line for pre-filled syringes and vials at its production facilities...

A New Initiative To Assess Clinical Trials Carbon Footprint

The Clinical Trials Environmental Impact Community of Interest (CoI), a cooperative effort that aims to determine the carbon footprint of centralised and decentralised clinical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read